Histone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesis

Cancer Sci. 2010 Apr;101(4):869-75. doi: 10.1111/j.1349-7006.2009.01460.x. Epub 2009 Dec 8.

Abstract

Peroxisome proliferators (PPs), non-genotoxic rodent carcinogens, cause the induction of the peroxisomal fatty acid beta-oxidation system, including bifunctional enzyme (BE) and 3-ketoacyl-CoA thiolase (TH), in the liver. GST M1 gene is polymorphic in Sprague-Dawley rats, NC- and KS-type. The KS-type rats showed enhanced susceptibility to ethyl-alpha-chlorophenoxyisobutyrate (clofibrate, CF), one of the PPs. The degree of BE induction was higher in the KS-type and preneoplastic foci developed after 6-8 weeks of treatment, whereas no foci developed in the NC-type. In the preset study, factors involved in different BE inducibility were investigated. There were no differences in hepatic peroxisome proliferator-activated receptor (PPAR) alpha levels between them. Among various coactivators for PPARalpha, only steroid receptor coactivator (SRC)-3 level was higher in the KS-type. To investigate the association between PPARalpha and SRC-3 or other proteins, nuclear extracts from CF-treated livers were applied to a PPARalpha column. In the KS-type, 110, 72, and 42 kDa proteins were bound and these were identified as SRC-3, BE, and TH, respectively. EMSA supported the binding of these proteins to PPARalpha associated to the BE enhancer in CF-treated KS-type, but not in the NC-type. Histone H3 acetylation was increased 11-fold in the KS-type by CF treatment but not in the NC-type. As BE and TH are responsible for acetyl-CoA production and SRC-3 possesses a histone acetyltransferase activity, these results suggest that enhanced BE induction in the KS-type livers is due to acetylation-mediated transcriptional activation and epigenetic mechanisms might be involved in CF-induced rat hepatocarcinogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetyl Coenzyme A / genetics
  • Acetyl Coenzyme A / metabolism
  • Acetyl Coenzyme A / pharmacology
  • Acetyl-CoA C-Acetyltransferase / genetics
  • Acetyl-CoA C-Acetyltransferase / metabolism*
  • Acetylation
  • Animals
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Clofibrate
  • Enzyme Induction
  • Fatty Acids / genetics
  • Fatty Acids / metabolism
  • Fatty Acids / pharmacology
  • Histones / genetics
  • Histones / metabolism*
  • Histones / pharmacology
  • Liver / drug effects
  • Liver / enzymology
  • Liver / metabolism*
  • Liver Neoplasms, Experimental / chemically induced
  • Liver Neoplasms, Experimental / metabolism*
  • Male
  • Nuclear Receptor Coactivator 3 / metabolism
  • PPAR alpha / genetics
  • PPAR alpha / metabolism
  • PPAR alpha / pharmacology
  • Peroxisome Proliferators / metabolism
  • Peroxisome Proliferators / pharmacology
  • Polymorphism, Genetic
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Steroid / genetics
  • Receptors, Steroid / metabolism

Substances

  • Fatty Acids
  • Histones
  • PPAR alpha
  • Peroxisome Proliferators
  • Receptors, Steroid
  • Acetyl Coenzyme A
  • Nuclear Receptor Coactivator 3
  • Acetyl-CoA C-Acetyltransferase
  • Clofibrate